Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)

The summary for the Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01): The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications to test the hypothesis that reductions in illicit drug use are associated with improved health outcomes in patients. This FOA will support both prospective and retrospective studies, which may include, but not limited to, identification and characterization of beneficial health outcomes that are associated with reduced levels of drug use. Such studies may focus on identification and or validation of strategies, methods, and tools (including biomarkers) that can assess the salutary consequences resulting from reduced use of a particular illicit drug. These objectives may be achieved either by developing new or validating currently available methodologies that will monitor a health outcome associated with changes in use of a particular illicit drug. Further, identifying health outcomes associated with changes in drug use will stimulate translational research by providing additional measures of health effects linked to drug abuse, and may also be useful in evaluating the efficacy of new therapeutic agents for treating substance use disorders (SUDs). The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs.

Federal Grant Title:	Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DA-13-007
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse and Addiction Research Programs
Current Application Deadline:	Aug 22, 2012
Original Application Deadline:	Aug 22, 2012
Posted Date:	May 11, 2012
Creation Date:	May 11, 2012
Archive Date:	Sep 22, 2012
Total Program Funding:	$3,000,000
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clini...; • Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Betwee...; • Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Betwee...; • Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Func...; • Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Funct...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed); • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed); • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...; • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...; • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...